Seminars in Nuclear Medicine
Volume 38, Issue 1 , Pages 67-81 , January 2008

Decision Support Systems in Diuresis Renography

  • Andrew Taylor, MD

      Affiliations

    • Department of Radiology, Emory University School of Medicine, Atlanta, GA.
    • Corresponding Author InformationAddress reprint requests to Andrew Taylor, MD, Nuclear Medicine, Department of Radiology, Emory University Hospital, 1364 Clifton Rd NE, Atlanta, GA 30322.
    • ,
  • Amita Manatunga, PhD

      Affiliations

    • Department of Biostatistics, Emory University School of Medicine, Atlanta, GA.
    • ,
  • Ernest V. Garcia, PhD

      Affiliations

    • Department of Radiology, Emory University School of Medicine, Atlanta, GA.

References 

  1. Iglehart J. The new era of medical imaging—progress and pitfalls. N Eng J Med. 2006;354:2822–2828
  2. IMV Medical information division. In: 2003 Nuclear Medicine Census Market Summary Report. Des Plaines, IL: IMV Limited; 2003;p. 7–11IV
  3. Hunsche A: Value of quantitative data in the interpretation of diuresis renography for suspected urinary tract obstruction. PhD Thesis: Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil, 2006
  4. Taylor A, Nally J, Aurell M, et al. Consensus report on ACE inhibitor renography for detecting renovascular hypertension. J Nucl Med. 1996;37:1876–1882
  5. O’Reilly P, Aurell M, Britton K, et al. Consensus on diuresis renography for investigating the dilated upper urinary tract. J Nucl Med. 1996;37:1872–1876
  6. Blaufox MD, Aurell M, Bubeck B, et al. Report of the radionuclides in nephrourology committee on renal clearance. J Nucl Med. 1996;37:1883–1890
  7. Prigent A, Cosgriff P, Gates GF, et al. Consensus report on quality control of quantitative measurements of renal function obtained from the renogram: International consensus committee from the scientific committee of Radionuclides in Nephrourology. Sem Nucl Med. 1999;29:146–159
  8. Dubovsky EV, Russell CD, Bischof-Delaloye A, et al. Report of the radionuclides in nephrourology committee for evaluation of transplanted kidney (review of techniques). Semin Nucl Med. 1999;29:175–188
  9. Gordon I, Colarinha P, Fettich J, et al. Guidelines for standard and diuretic renography in children. Eur J Nucl Med. 2001;28:BP21–BP30
  10. Cosgriff PS, Stevens D: Impact of radionuclides in mephrourology guidelines. Alasbimn J, 2001. Available at www.alasbimnjournal.cl
  11. Fujita H, Katafuchi T, Uehara T, et al. Application of neural network to computer-aided diagnosis of coronary artery disease in myocardial SPECT Bull’s-eye images. J Nucl Med. 1992;33:272–276
  12. Porenta G, Dorffner G, Kundrat S, et al. Automated interpretation of planar thallium-201-dipyridamole stress-redistribution scintigrams using artificial neural networks. J Nucl Med. 1994;35:2041–2047
  13. Hamilton D, Riley PJ, Miola UJ, et al. A feed forward neural network for classification of bull’s-eye myocardial perfusion images. Eur J Nucl Med. 1995;22:108–115
  14. Lindahl D, Palmer J, Ohlsson M, et al. Automated interpretation of myocardial SPECT perfusion images using artificial neural networks. J Nucl Med. 1997;38:1870–1875
  15. Lindahl D, Palmer J, Pettersson J, et al. Scintigraphic diagnosis of coronary artery disease: Myocardial Bull’s-eye images contain the important information. Clin Physiol. 1998;18:554–561
  16. Lindahl D, Lanke J, Lundin A, et al. Improved classifications of myocardial bull’s-eye scintigrams with computer-based decision support system. J Nucl Med. 1999;40:96–101
  17. Lindahl D, Palmer J, Edenbrandt L. Myocardial SPET: artificial neural networks describe extent and severity of perfusion defects. Clin Physiol. 1999;19:497–503
  18. Lindahl D, Toft J, Hesse B, et al. Scandinavian test of artificial neural network for classification of myocardial perfusion images. Clin Physiol. 2000;20:253–261
  19. Haddad M, Adlassnig KP, Porenta G. Feasibility analysis of a case-based reasoning system for automated detection of coronary heart disease from myocardial scintigrams. Artif Intell Med. 1997;9:61–78
  20. Gabor FV, Datz FL, Christian PE. Image analysis and categorization of ventilation-perfusion scans for the diagnosis of pulmonary embolism using an expert system. J Nucl Med. 1994;35(5):797–802
  21. Hamilton D, Ueber JM, Mousa D. Interpretation of captopril transplant renography using a feed forward neural network. J Nucl Med. 1996;37:1649–1652
  22. Nielsen M, Granerus G, Ohlsson M, et al. Interpretation of captopril renography using artificial neural networks. Clin Physiol Funct Imaging. 2005;25:293–296
  23. Imran MB, Kawashima R, Sato K, et al. Detection of CBF deficits in neuropsychiatric disorders by an expert system: a 99mTc-HMPAO brain SPET study using automated image registration. Nuc Med Comm. 1999;20:25–32
  24. Porenta G, Dorffner G, Kundrat S, et al. Automated interpretation of planar thallium-201-dipyridamole stress-redistribution scintigrams using artificial neural networks. J Nucl Med. 1994;35:2041–2047
  25. Ezquerra N, Mullick R, Cooke D, et al. PERFEX: An expert system for interpreting 3d myocardial perfusion. Expert Systems with Applications. 1993;6:459–468
  26. Garcia EV, Cooke CD, Folks RD, et al. Diagnostic performance of an expert system for the interpretation of myocardial perfusion SPECT studies. J Nucl Med. 2001;42:1185–1191
  27. Gorry G. Computer-assisted clinical decision making. Met Info Med. 1973;12:45–51
  28. Shortliffe EH. Computer-Based Medical Consultations: MYCIN. In: Amsterdam, Netherlands: Elsevier; 1976;p. 264
  29. Kuyvenhoven J, Piepsz A, Ham H. When could the administration of furosemide be avoided. Clin Nucl Med. 2003;28:732–737
  30. Taylor A, Corrigan P, Galt J, et al. Measuring technetium-99m-MAG3 clearance with an improved camera based method. J Nucl Med. 1995;36:1689–1695
  31. Taylor A, Manatunga A, Morton K, et al. Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance. Radiology. 1997;204:47–54
  32. Garcia EV, Taylor A, Halkar R, et al. RENEX: An expert system for the interpretation of 99mTc-MAG3 scans to detect renal obstruction. J Nucl Med. 2006;47:320–329
  33. Folks RD, Taylor AT, Garcia EV. Development and prospective evaluation of an automated software system for quality control of quantitative Tc-99m MAG3 renal studies. J Nucl Med Tech. 2007;35:27–33
  34. Taylor A, Lewis C, Giacometti A, et al. Improved formulas for the estimation of renal depth in adults. J Nucl Med. 1993;34:1766–1769
  35. Taylor A. Formulas to estimate renal depth in adults (letter to the editor). J Nucl Med. 1994;35:2054–2055
  36. Taylor A, Thakore K, Folks R, et al. Background subtraction in technetium-99m-MAG3 renography. J Nucl Med. 1997;38:74–79
  37. Hunsche A, Press H, Taylor A. Increasing the dose of furosemide in patients with azotemia and suspected obstruction. Clin Nucl Med. 2004;29:149–153
  38. Müller-Suur R, Tidgren B, Lundberg HJ. Effect of captopril on MAG3 clearance in patients with and without renal artery stenosis and after PTRA. Eur J Nucl Med. 1998;25:845
  39. Taylor A, Blaufox MD, Dubovsky EV, et al: Procedure guideline for the diagnosis of renovascular hypertension. Policy and practice, procedure guidelines. June, 2003. Available at: Snm.org
  40. Li Y, Russell CD, Palmer-Lawrence J, et al. Quantitation of renal parenchymal retention of technetium-99m-MAG3 in renal transpleants. J Nucl Med. 1994;35:846–850
  41. Piepsz A, Tondeur M, Ham H: NORA. A simple and reliable parameter for estimating renal output with or without frusemide challenge. Nucl Med Comm. 2000;21:317–323
  42. Gordon I, Mialdea-Fernandex RM, Peters AM. Pelviureteric junction obstruction (The value of a post-micturition view in 99mTc DTPA diuretic renography). Br J Urol. 2000;61:409–412
  43. Wong DC, Rossleigh MA, Farnsworth RH. Diuretic renography with the addition of quantitative gravity-assisted-drainage in infants and children. J Nucl Med. 2000;41:1030–1036
  44. Strauss BS, Blaufox MD. Estimation of residual urine volume and urine flow rates without ureteral catherization. J Nucl Med. 1970;11:81–84
  45. Esteves FP, Taylor A, Manatunga A, et al. Tc-99m MAG3 renography: normal values for camera-based 99m-Tc MAG3 clearance, MAG3 curve parameters, excretory parameters and residual urine volume. AJR Am J Roentgenol. 2006;187:W610–W619
  46. Klingensmith WC, Briggs DE, Smith WI. Technetium-99m-MAG3 renal studies: Normal range and reproducibility of physiologic parameters as a function of age and sex. J Nucl Med. 1994;35:1612–1617
  47. Lin WY, Changlai SP, Kao CH. Normal ranges of renal physiological parameters for technetium-99m mercaptoacetyltriglycine and the influence of age and sex using a camera-based method. Urol Int. 1998;60:11–16
  48. Clausen TD, Kanstrup I, Jensen J. Reference values for 99mTc-MAG3 renography determined in healthy, potential renal donors. Clin Physiol Func Imaging. 2002;22:356–360
  49. Schlegel JU, Jamway SA. Individual renal plasma flow determination in 2 minutes. J Urol. 1976;116:282–285
  50. Gates GF. Glomerular filtration rate: Estimation from fractional renal acculmulation of Tc-99m DTPA. AJR Am J Roentgenol. 1982;138:565–570
  51. Russell CD, Dubovsky EV. Single-sample Tc-99m MAG3 renal clearance in the long-term management of patients with spinal cord injury. Nucl Med Commun. 1998;19:494–498
  52. Bubeck B. Renal clearance determination with one blood sample: Improved accuracy and universal applicability by a new calsulation principle. Semin Nucl Med. 1993;23:73–76
  53. Chachati A, Meyers A, Godon JP, et al. Rapid method for the measurement of differential renal function: Validation. J Nucl Med. 1987;28:829–836
  54. Bocher M, Shrem Y, Tappiser A, et al. Tc-99m mercaptoacetyltriglycine—clearance comparison of camera-assisted methods. Clin Nucl Med. 2001;26:745–750
  55. Russell CD, Dubovsky EV. Gates method for FR measurement (letter). J Nucl Med. 1986;27:1373–1374
  56. Esteves FP, Halkar RK, Issa MM, et al. Evaluation of renal function: A comparison between the camera-based Tc-99n MAG3 and 24-hour creatinine clearances. AJR Am J Roentgenol. 2006;187:W316–W319
  57. Halkar R, Taylor A, Manatunga A, et al. Monitoring renal function: A prospective study comparing camera-based Tc-99m mercaptoacetyltriglycine clearance and creatinine clearance. Urology. 2007;69:426–430
  58. Russell CD, Taylor AT, Dubovsky EV. Measurement of renal function with technetium-99m-MAG3 in children and adults. J Nucl Med. 1996;37:588–593
  59. El-Galley R, Clarke HS, O’Brien DP, et al. Normal parameters for Tc- 99m MAG3 renography. J Nucl Med. 1998;39:87P
  60. Inoue Y, Ohtake T, Yokoyama I, et al. Evaluation of renal function from 99mTc-MAG3 renography without blood sampling. J Nucl Med. 1999;40:793–798
  61. Itoh K, Nonomura K, Yamashita T, et al. Quantification of renal function with a count-based gamma method using technetium-99m-MAG3 in children. J Nucl Med. 1996;37:71–75
  62. Garcia EV, Taylor A, Manatunga D, et al. A software engine to justify the conclusions of an expert system’s conclusions for detecting renal obstruction on Tc-99m MAG3 Scans. J Nucl Med. 2007;48:463–470
  63. Breiman L, Friedman J, Olshen R, et al. Classification and Regression Trees. Belmont, CA: Wadsworth; 1984;
  64. Binongo JNG, Taylor A, Manatunga A, et al. Use of Classification and Regression Trees in Diuresis Renography. Acad Radiol. 2007;14:306–311
  65. Efron B, Tibshirani R. An Introduction to the Bootstrap. London: Chapman and Hall; 1993;
  66. Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction, section 9.2. In: New York: Springer; 2001;p. 246–250
  67. Thrall JH, Ziessman HA. Nuclear Medicine: The Requisites. In: St. Louis, MO: Mosby-Year Book, Inc; 1995;p. 302
  68. Piepsz A, Kuyvenhoven JD, Tondeur M, Ham H. Normalized residual activity: Usual values and robustness of the method. J Nucl Med. 2002;43:33–38
  69. Taylor A, Hill A, Binongo J, et al. Evaluation of two diuresis renography decision support systems designed to determine the need for furosemide in patients with suspected obstruction. AJR Am J Roentgenol. 2007;188:1395–1402
  70. Binongo JNG, Yuan M, Bao J, et al. Prediction based two-stage modeling. Joint Stat Meetings Proc. 2006;2006:3967–3972
  71. Folks RD, Taylor AT, Garcia EV. Development and prospective evaluation of an automated software system for quality control of quantitative Tc-99m MAG3 renal studies. J Nucl Med Tech. 2007;35:27–33
  72. Taylor A, Garcia EV, Folks R, et al. Preliminary diagnostic performance of RENEX, an expert system to detect renal obstruction using Tc-99m MAG3. J Nucl Med. 2006;47:147P
  73. Porenta G. Being right for the right reason: Better than just being right?. J Nucl Med. 2007;48:335–336
  74. Sundaram PS, Padma S, Bhat S, Sanjeevan KV, Rahul C. F + 10 diuretic renography protocol is better than F-15 in followup of post pyeloplasty patients. J Nucl Med. 2003;44:359P
  75. Sfakianakis GN, Cohen DJ, Braunstein RH, et al. MAG3-F0 scintigraphy in decision making for emergency intervention in renal colic after helical CT positive for a urolith. J Nucl Med. 2000;41:1813–1822

 This work was supported by a grant from the National Library of Medicine, R01-LM007595. Two authors (A.T., E.V.G.) receive royalties from the sale of the application software QuantEM 1.0 related to the research described herein. The terms of the arrangement have been reviewed and approved by Emory University in accordance with its conflict-of-interest practice.

PII: S0001-2998(07)00097-9

doi: 10.1053/j.semnuclmed.2007.09.006

Seminars in Nuclear Medicine
Volume 38, Issue 1 , Pages 67-81 , January 2008

Article Tools

* Image Usage & Resolution